Refine by
Diabetic Peripheral Articles & Analysis
3 news found
The cohort included limited ambulatory status (37.5%) and a high burden of comorbidities, including diabetes (27.5%), peripheral artery disease (25.0%), and autoimmune disease (25.0%), and the study is available as a pre-print.In addition, 13 abstracts spanning multiple specialties will be presented at the symposium’s poster reception on Friday, April 10, 2026, ...
ByKerecis
PMC-402 is a TIE2-activating antibody that stabilizes dysfunctional leaky disorganized pathological vessels. Diabetic patients with Diabetic Peripheral Neuropathy will be recruited for Phase I trial. ...
REDWOOD CITY, Calif., Jan. 25, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today responded to Medtronic's announcement of FDA approval for painful diabetic neuropathy (PDN). "PDN represents a very large potential market, and having another competitor validate this large ...